Key facts for C9399
- Medicare payment
- paid outside OPPS
- OPPS SI A: another fee schedule or payment system
- Coverage code
- D
- special coverage instructions apply
- MUE
- none published
- no MUE in the 2026 Q4 tables
- NCCI PTP pairs
- 0
- practitioner file
- LCDs and articles
- 2 / 3
TL;DR
C9399 is a Level II code from the C section (hospital outpatient prospective payment system, temporary codes), in use since 2004: "Unclassified drugs or biologicals". None of the October 2026 PFS, DMEPOS, CLFS, OPPS or ASC files lists a national amount for C9399; its HCPCS pricing indicator is 53 (statute). Its OPPS status indicator is A, which the I/OCE table defines as "Services not paid under OPPS; paid under fee schedule or other payment system": Medicare pays C9399 under a fee schedule or payment system other than OPPS. 2 active LCDs and 3 billing and coding articles list C9399 across 14 states: L33394 (Drugs and Biologicals, Coverage of, for Label and Off-Label Uses), L34338 (Transthoracic Echocardiography (TTE)), A52451, A55913. HCPCS record: BETOS O1E (other drugs); pricing indicator 53; type of service 1 (medical care). Nearby codes: C9600, C9601, C9602, C9604.
C9399 descriptor and code status
The October 2026 HCPCS Level II file describes C9399 as “Unclassified drugs or biologicals”. It sits in the C section (hospital outpatient prospective payment system, temporary codes), listed with the other C codes. Although searches often call it the "C9399 CPT code", C9399 is a HCPCS Level II code maintained by CMS, not an AMA CPT code; both go in the same procedure-code field on the claim.
| Field | Value |
|---|---|
| Short descriptor | Unclassified drugs or biolog |
| Added to HCPCS | 2004-01-01 |
| Last action | N (no maintenance), effective 2004-01-01 |
| Coverage code | D: special coverage instructions apply |
| Pricing indicator | 53: statute |
| BETOS category | O1E: other drugs |
| Type of service | 1: medical care |
| Statute | 621MMA |
Medicare payment for C9399
None of the October 2026 PFS, DMEPOS, CLFS, OPPS or ASC files lists a national amount for C9399; its HCPCS pricing indicator is 53 (statute). Its OPPS status indicator is A, which the I/OCE table defines as "Services not paid under OPPS; paid under fee schedule or other payment system": Medicare pays C9399 under a fee schedule or payment system other than OPPS. The amounts below are national figures from the October 2026 CMS files; the contractor applies the locality, rural or state adjustment and the beneficiary's cost sharing.
Hospital outpatient (OPPS Addendum B)
Status indicator A (Services not paid under OPPS; paid under fee schedule or other payment system), with no separate OPPS payment rate.
Ambulatory surgical center (Addendum BB)
Payment indicator K7 (Unclassified drugs and biologicals; payment contractor-priced).
Medically Unlikely Edits for C9399
CMS publishes no MUE for C9399 in the 2026 Q4 practitioner, facility or DME supplier tables. Some MUE values are confidential and applied without publication, so unit limits can still deny; document the quantity furnished on every claim.
The MUE lookup for C9399 shows every setting next to any other code on the same claim.
NCCI edits and add-on rules
No active practitioner PTP pair lists C9399 in v323r0.
C9399 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Pair counts show exposure, not the answer for one claim. Check C9399 against a second code to see whether the pair bundles and whether a modifier can separate the services.
Medicare coverage policies for C9399
2 active Local Coverage Determinations and 3 billing and coding articles list C9399. Each applies only in its contractor's jurisdiction, and the article carries the diagnosis codes that support the item or service.
- LCD L33394: Drugs and Biologicals, Coverage of, for Label and Off-Label Uses · Wellpoint Federal
- L34338 Transthoracic Echocardiography (TTE) · CGS Administrators, LLC
| Article | Title | Contractor(s) | Related LCD |
|---|---|---|---|
| A52451 | Billing and Coding: Ranibizumab, Aflibercept and biosimilars | Wellpoint Federal | L33394 |
| A55913 | Billing and Coding: Hospital Outpatient Drugs and Biologicals Under the Outpatient Prospective Payment System (OPPS) | Palmetto GBA | — |
| A57306 | Billing and Coding: Transthoracic Echocardiography (TTE) | CGS Administrators, LLC | L34338 |
Denials to expect on C9399
the diagnosis or documentation does not meet the LCD or billing article that lists C9399
the modifier reported is inconsistent with the code
the claim lacks information needed to adjudicate the line, such as an order, NPI or required modifier
Where QuickIntell fits for C9399 claims
QuickCode supports qualified coder review of units, modifiers and NCCI pairs for C9399 before the claim leaves, and QuickRCM carries claim readiness and the denial follow-up when an edit or coverage policy is missed.
Frequently asked questions: HCPCS C9399
What does HCPCS code C9399 describe?
"Unclassified drugs or biologicals" (short descriptor "Unclassified drugs or biolog"), in the C section (hospital outpatient prospective payment system, temporary codes). Added 2004-01-01.
Is C9399 a CPT code?
It is not. C9399 belongs to the C section (hospital outpatient prospective payment system, temporary codes) of HCPCS Level II, the CMS code set, not to AMA CPT. "C9399 CPT code" searches refer to it.
What does Medicare pay for C9399?
None of the October 2026 PFS, DMEPOS, CLFS, OPPS or ASC files lists a national amount for C9399; its HCPCS pricing indicator is 53 (statute). Its OPPS status indicator is A, which the I/OCE table defines as "Services not paid under OPPS; paid under fee schedule or other payment system": Medicare pays C9399 under a fee schedule or payment system other than OPPS.
Does Medicare cover C9399?
Coverage code D (special coverage instructions apply). 2 active LCDs and 3 billing and coding articles list C9399 across 14 states: L33394 (Drugs and Biologicals, Coverage of, for Label and Off-Label Uses), L34338 (Transthoracic Echocardiography (TTE)), A52451, A55913.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-10. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- Integrated Outpatient Code Editor v27.3 data tables: status and payment indicatorsVersion I/OCE v27.3 (October 2026) · effective 2026-10-01 · file Data_Status_Indicator.txtSHA-256 78f119ef0a435351…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-10-08 · effective 2026-10-04 · file article.csvSHA-256 5e95c4a8ac3664be…
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-10-08 · effective 2026-10-04 · file lcd.csvSHA-256 9aee1bd7f14056b0…
Disclaimer
This page is an operational reference compiled from CMS publications: the HCPCS Level II file, the physician, DMEPOS and clinical laboratory fee schedules, OPPS and ASC addenda, NCCI MUE, PTP and add-on edit tables and the Medicare Coverage Database. Amounts are Medicare national figures before locality and state adjustment; Medicaid and commercial payers set their own. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.